TP53 and cancer: Another possible explanation why combinatorial CTX+Ganet preferentially affects mutp53Q/− versus p53null tumors is that mutp53Q/− cancer cells proliferate faster than p53null cells, since growth advantage over simple p53 absence is one of the phenotypes of mutp53 gain-of-function.15 This could result in their higher sensitivity to the DNA-alkylating CTX.